Eye-minders
Products to Enhance Safety and Based on Eye-movement Analysis.
Company Overview
Snapshot
Founded in October 2017 by Daphna Palti-Wasserman, Eye-minders operates with 1–10 employees. The company has raised $5.8 million across one funding round from one investor. Eye-minders was selected by MAFAAT (Israel’s Directorate of Defense R&D) to lead a PTSD diagnostics pilot, in collaboration with leading hospitals, including Sheba Medical Center.
Business overview
Eye-minders is a deep-tech company that develops patented AI algorithms to analyze eye movements and pupil dynamics, extracting biomarkers of cognitive and emotional load. Its core technology is applied in its first commercial product for credibility assessment, currently utilized by private companies and government agencies. The company is expanding into clinical mental health, focusing on medical applications such as PTSD diagnostics, and operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare, Digital Therapeutics, and Digital Medical Diagnostics.
Strategic signal
In March 2024, Eye-minders was featured in CTech for its innovative approach to understanding human cognition and emotion through eye analysis. This highlights the company's progress in leveraging AI and eye-tracking technology to develop solutions that go beyond traditional methods, signaling a potential for significant impact in both credibility assessment and clinical mental health diagnostics.
Company Intelligence Q&A
- What is Eye-minders' primary focus?
- Eye-minders focuses on developing patented AI algorithms that analyze eye movements and pupil dynamics to extract biomarkers of cognitive and emotional load, with applications in credibility assessment and clinical mental health.
- When was Eye-minders founded?
- Eye-minders was founded in October 2017.
- Who is the founder of Eye-minders?
- Daphna Palti-Wasserman is the Founder & CEO of Eye-minders.
- What is Eye-minders' total disclosed funding?
- Eye-minders has raised a total of $5.8 million across one funding round. This funding was secured at the Series A stage.
- What significant clinical initiative is Eye-minders involved in?
- Eye-minders was selected by MAFAAT (Israel’s Directorate of Defense R&D) to lead a PTSD diagnostics pilot, in collaboration with leading hospitals, including Sheba Medical Center, marking its first clinical initiative.